Načítá se...
Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs
Current drugs for the treatment of visceral leishmaniasis are inadequate. No novel compound is in the pipeline. Since economic returns on developing a new drug for neglected disease, leishmaniasis is so low that therapeutic switching represents the only realistic strategy. It refers to “alternative...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer-Verlag
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3235389/ https://ncbi.nlm.nih.gov/pubmed/23024489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-011-0040-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|